F. Ringshausen (Hannover, Germany), O. Burghuber (Wien, Austria), M. Loebinger (London, United Kingdom), C. Prados Sánchez (Madrid, Spain)
Explorative analyses of inflammatory pathways and the effect of azithromycin in bronchiectasis patients
Y. Sabogal Piñeros (Amsterdam , Netherlands), J. Altenburg (Amsterdam , Netherlands), S. Vijverberg (Amsterdam , Netherlands), E. Hoefsmit (Amsterdam , Netherlands), B. Dierdorp (Amsterdam , Netherlands), T. Dekker (Amsterdam , Netherlands), W. Boersma (Amsterdam , Netherlands), R. Lutter (Amsterdam , Netherlands)
|  |
Objective cough count in bronchiectasis patients is reproducible and relates to quality of life
A. Key (Liverpool, United Kingdom), K. Holt (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), P. Walker (Liverpool, United Kingdom)
| |
Cardiac Involvement In Chronic Obstructive Pulmonary Disease (COPD) Secondary To Post TB Bronchiectasis V/S Non Post Tb Bronchiectasis
K. Utsav (Varanasi, India)
| |
Gender differences in patients admitted by exacerbation of bronchial asthma with bronchiectasis
J. Teran Tinedo (Madrid, Spain), G. Sánchez Muñoz (Madrid, Spain), C. Castro Riera (Madrid, Spain), Z. Ji (Madrid, Spain), A. López De Andres (Madrid, Spain), R. Jiménez García (Madrid, Spain), V. Hernández Barrera (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Díez (Madrid, Spain)
| |
Validation of the Danish version of the Bronchiectasis Health Questionnaire (BHQ)
M. Hvass (Aalborg, Denmark), T. Gissel (Viborg, Denmark), J. Fly (Viborg, Denmark), K. Børsting (Viborg, Denmark), A. Spinou (London, United Kingdom), U. Weinreich (Aalborg, Denmark)
|  |
The radiographic bronchiectasis in patients with COPD-OSA overlap syndrome
X. Yang (Tianjin, China), X. Tang (Tianjin, China), J. Cao (Tianjin, China), L. Dong (Tianjin, China)
| |
Factors associated with length of stay of hospitalised exacerbations for non-cystic fibrosis bronchiectasis
I. Fong (Singapore, Singapore), S. Loh (Singapore, Singapore), A. Taha (Singapore, Singapore), K. Tham (Singapore, Singapore), A. Yii (Singapore, Singapore)
| |
Cross-sectional evaluation of serum and sputum calprotectin in bronchiectasis disease monitoring
D. Raats (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), M. Fogelström (Leuven, Belgium), L. Dupont (Leuven, Belgium), N. Lorent (Leuven, Belgium)
| |
FEV1 measurement at home versus measurement in the hospital in children with asthma and cystic fibrosis
R. Gerzon (Maastricht, Netherlands), Q. Jöbsis (Maastricht, Netherlands), M. Bannier (Maastricht, Netherlands), B. Winkens (Maastricht, Netherlands), E. Dompeling (Maastricht, Netherlands)
| |
Co-existence of Bronchiectasis and COPD. Comparison to COPD or Bronchiectasis alone.
A. Dimakou (Athens, Greece), M. Kaponi (Athens, Greece), S. Koukidou (Athens, Greece), O. Papaioannou (Athens, Greece), A. Digalaki (Athens, Greece), A. Gousiou (Athens, Greece), G. Hillas (Athens, Greece)
| |
The association between bronchiectasis and systemic inflammation
A. Jarrar (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), R. Fessi (Tunis, Tunisia), M. Ferchichi (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
J. Busby (Belfast, United Kingdom), D. Jackson (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), S. Siddiqu (Leicester, United Kingdom), L. Heaney (Belfast, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), P. Pfeffer (London, United Kingdom)
| |
Depression in patients with Non-Cystic Fibrosis Bronchiectasis
G. Cacopardo (Catania, Italy), F. Cumbo (Catania, Italy), L. Spicuzza (Catania, Italy), R. Campisi (Catania, Italy), C. Crimi (Catania, Italy), G. Saitta (Catania, Italy), F. Sebastian (Milano, Italy), E. Aguglia (Catania, Italy), N. Crimi (Catania, Italy)
| |
Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis
S. Lee (Jinju, Republic of Korea), J. Lee (Jinju, Republic of Korea)
| |
Risk factors for the decline of pulmonary function among bronchiectasis patients in Japan
M. Fujita (Fukuoka , Japan), T. Sasaki (Fukuoka , Japan), R. On (Fukuoka , Japan), T. Ikeda (Fukuoka , Japan), T. Matsumoto (Fukuoka , Japan)
| |
Haemoptysis amongst Asian Non-Cystic Fibrosis Bronchiectasis patients: a unique phenotype
S. Young (Singapore, Singapore), S. Chew (Singapore, Singapore), C. Leong (Singapore, Singapore), P. Tiew (Singapore, Singapore), M. Koh (Singapore, Singapore), G. Tan (Singapore, Singapore), K. Lee (Singapore, Singapore)
| |
Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index
A. Jarrar (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), R. Fessi (Tunis, Tunisia), M. Ferchichi (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Which score is better in association with exercise capacity and QoL in noncystic fibrosis bronchiectasis patients? FACED or BSI?
Y. Varol (Izmir, Turkey), H. Sahin (Izmir, Turkey), N. Aksel (Izmir, Turkey), A. Cirak (Izmir, Turkey)
| |
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
S. Atis Nayci (Mersin, Turkey), E. Ozgur (Mersin, Turkey), G. Çavusoglu Bozdogan (Ankara, Turkey), C. Özge (Mersin, Turkey)
| |
Age-associated change in respiratory microbiome architecture in healthy Singaporean subjects
M. Mac Aogáin (Singapore, Singapore), N. Ali (Singapore, Singapore), A. Tsang (Singapore, Singapore), S. Lee (Singapore, Singapore), K. Fam (Singapore, Singapore), M. Yap (Singapore, Singapore), C. Lim (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)
| |